{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:28:01Z","timestamp":1789057681573,"version":"build-2803163510"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Chronic kidney disease (CKD) is a global public health concern that causes a remarkable disease burden. Although the prevalence of CKD in China has been investigated by previous national surveys, the incidence, disability-adjusted life years (DALYs), and death of CKD and their temporal trends over the past decades have not been well studied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Incidence, DALYs, and death of CKD, as well as risk-attributable DALYs and death in China from 1990 to 2023, were checked from the Global Burden of Diseases, Injuries, and Risk Factors Study 2023. The temporal trend of each indicator was estimated by join point analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>In 2023, in China, there were 156.15 (95% uncertainty interval: 146.77\u2013167.88) million patients with CKD. The incidence, DALYs, and death rates of CKD were 240.59 (222.83\u2013266.12), 355.86 (303.29\u2013407.63), and 10.73 (8.96\u201312.70) per 100,000 population, respectively. Females had a higher incidence but lower DALYs and death rates than males. The elderly population had a much higher disease burden than middle-aged and young people. Incidence rates markedly increased, DALY rates slightly decreased, while death rates mildly increased from 1990 to 2023 with the respective average annual percent change of 1.67%, \u20130.17%, and 0.40%. However, the metrics all tended to decline after age standardization. Metabolic risk factors accounted for higher risk-attributable DALYs and deaths than other risk factors. High fasting plasma glucose ranked first in 2023 for risk-attributable DALYs and death, while high body mass index was the only risk factor maintaining a nondeclining contribution when comparing 2010 to 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>CKD bears high levels of incidence, DALYs, and death in China, with an increasing trend for incidence observed from 1990 to 2023. The aging of the population and metabolic diseases are the main drivers of the CKD burden. Priority should be given to curb the CKD epidemic.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cm9.0000000000004162","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:00:09Z","timestamp":1782709209000},"page":"2309-2317","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Incidence, DALYs, and death rates of chronic kidney disease in China, 1990\u20132023: Results from the Global Burden of Disease Study 2023"],"prefix":"10.1097","volume":"139","author":[{"given":"Jinwei","family":"Wang","sequence":"first","affiliation":[{"name":"Renal Division, Department of Medicine, Peking University First Hospital, Beijing 100034, China"},{"name":"State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing 100191, China"},{"name":"Research Units of Diagnosis and Treatment of Immune-Mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Zhao","sequence":"additional","affiliation":[{"name":"Renal Division, Department of Medicine, Peking University First Hospital, Beijing 100034, China"},{"name":"State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing 100191, China"},{"name":"Research Units of Diagnosis and Treatment of Immune-Mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luxia","family":"Zhang","sequence":"additional","affiliation":[{"name":"Renal Division, Department of Medicine, Peking University First Hospital, Beijing 100034, China"},{"name":"State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing 100191, China"},{"name":"Research Units of Diagnosis and Treatment of Immune-Mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing 100730, China"},{"name":"National Institute of Health Data Science at Peking University, Beijing 100191, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"R1-20260805","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"key":"R2-20260805","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/S0140-6736(25)01853-7","article-title":"Global, regional, and national burden of chronic kidney disease in adults, 1990\u20132023, and its attributable risk factors: A systematic analysis for the Global Burden of Disease Study 2023","volume":"406","year":"2025","journal-title":"Lancet"},{"key":"R3-20260805","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"R4-20260805","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","article-title":"Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: Reference and alternative scenarios for 2016\u201340 for 195 countries and territories","volume":"392","author":"Foreman","year":"2018","journal-title":"Lancet"},{"key":"R5-20260805","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(12)60033-6","article-title":"Prevalence of chronic kidney disease in China: A cross-sectional survey","volume":"379","author":"Zhang","year":"2012","journal-title":"Lancet"},{"key":"R6-20260805","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/jamainternmed.2022.6817","article-title":"Prevalence of chronic kidney disease in China: Results from the sixth China chronic disease and risk factor surveillance","volume":"183","author":"Wang","year":"2023","journal-title":"JAMA Intern Med"},{"key":"R7-20260805","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1053\/j.ajkd.2014.01.012","article-title":"Awareness of CKD in China: A national cross-sectional survey","volume":"63","author":"Wang","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"R8-20260805","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMc1602469","article-title":"Trends in chronic kidney disease in China","volume":"375","author":"Zhang","year":"2016","journal-title":"N Engl J Med"},{"key":"R9-20260805","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1038\/s41591-022-01990-1","article-title":"The Global Burden of Disease Study at 30 years","volume":"28","author":"Murray","year":"2022","journal-title":"Nat Med"},{"key":"R10-20260805","article-title":"Guidelines for accurate and transparent health estimates reporting: The GATHER statement","volume":"13","author":"Stevens","year":"2016","journal-title":"PLoS Med"},{"key":"R11-20260805","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/S0140-6736(25)01637-X","article-title":"Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990\u20132023: A systematic analysis for the Global Burden of Disease Study 2023","volume":"406","year":"2025","journal-title":"Lancet"},{"key":"R12-20260805","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"key":"R13-20260805","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/bimj.201500263","article-title":"Projecting the future burden of cancer: Bayesian age-period-cohort analysis with integrated nested Laplace approximations","volume":"59","author":"Riebler","year":"2017","journal-title":"Biom J"},{"key":"R14-20260805","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijcard.2014.04.258","article-title":"Trends in incidence of hypertension in Chinese adults, 1991\u20132009: The China health and nutrition survey","volume":"175","author":"Liang","year":"2014","journal-title":"Int J Cardiol"},{"key":"R15-20260805","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2597953","article-title":"Incidence and time trends of type 2 diabetes mellitus among adults in Zhejiang province, China, 2007\u20132017","volume":"2020","author":"Wang","year":"2020","journal-title":"J Diabetes Res"},{"key":"R16-20260805","doi-asserted-by":"crossref","first-page":"473","DOI":"10.7326\/M16-0273","article-title":"Trends in prevalence of chronic kidney disease in the United States","volume":"165","author":"Murphy","year":"2016","journal-title":"Ann Intern Med"},{"key":"R17-20260805","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1681\/ASN.2005121273","article-title":"International comparison of the relationship of chronic kidney disease prevalence and ESRD risk","volume":"17","author":"Hallan","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R18-20260805","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.kint.2020.10.012","article-title":"The case for early identification and intervention of chronic kidney disease: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"99","author":"Shlipak","year":"2021","journal-title":"Kidney Int"},{"key":"R19-20260805","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1161\/CIRCULATIONAHA.123.068524","article-title":"Accelerated risk-based implementation of guideline-directed medical therapy for type 2 diabetes and chronic kidney disease","volume":"149","author":"Neuen","year":"2024","journal-title":"Circulation"},{"key":"R20-20260805","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.semnephrol.2022.04.001","article-title":"Sex and gender differences in chronic kidney disease and access to care around the globe","volume":"42","author":"Garc\u00eda","year":"2022","journal-title":"Semin Nephrol"},{"key":"R21-20260805","doi-asserted-by":"crossref","first-page":"F324","DOI":"10.1136\/bmj.f324","article-title":"Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: A meta-analysis","volume":"346","author":"Nitsch","year":"2013","journal-title":"BMJ"},{"key":"R22-20260805","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/CIRCULATIONAHA.116.024534","article-title":"Ischemia and no obstructive coronary artery disease (INOCA): Developing evidence-based therapies and research agenda for the next decade","volume":"135","author":"Bairey Merz","year":"2017","journal-title":"Circulation"},{"key":"R23-20260805","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)31561-0","article-title":"Sex and gender: Modifiers of health, disease, and medicine","volume":"396","author":"Mauvais-Jarvis","year":"2020","journal-title":"Lancet"},{"key":"R24-20260805","doi-asserted-by":"crossref","DOI":"10.1097\/CM9.0000000000003900","article-title":"Disease burden of non-communicable diseases attributable to high body mass index in China and its provinces, 1990\u20132021: A systematic analysis for the Global Burden of Disease Study 2021","author":"He","year":"2025","journal-title":"Chin Med J"},{"key":"R25-20260805","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1111\/dom.15238","article-title":"Prevalence of obesity and associated complications in China: A cross-sectional, real-world study in 15.8 million adults","volume":"25","author":"Chen","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"R26-20260805","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S2213-8587(21)00118-2","article-title":"Health policy and public health implications of obesity in China","volume":"9","author":"Wang","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R27-20260805","article-title":"Status of care for end-stage kidney disease in countries and regions worldwide: International cross sectional survey","volume":"367","author":"Bello","year":"2019","journal-title":"BMJ"},{"key":"R28-20260805","doi-asserted-by":"crossref","first-page":"A8","DOI":"10.1053\/j.ajkd.2024.01.001","article-title":"US renal data system 2023 annual data report: Epidemiology of kidney disease in the United States","volume":"83","author":"Johansen","year":"2024","journal-title":"Am J Kidney Dis"},{"key":"R29-20260805","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/j.ajkd.2020.11.021","article-title":"Estimation of prevalence of kidney disease treated with dialysis in China: A study of insurance claims data","volume":"77","author":"Yang","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"R30-20260805","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1016\/j.kisu.2020.09.001","article-title":"China kidney disease network (CK-NET) 2016 annual data report","volume":"10","author":"Zhang","year":"2020","journal-title":"Kidney Int Suppl (2011)"},{"key":"R31-20260805","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/CM9.0000000000003898","article-title":"Non-communicable disease burden in China, 1990-2023: Evidence from the Global Burden of Disease Study 2023","volume":"139","author":"Zhang","year":"2026","journal-title":"Chin Med J"},{"key":"R32-20260805","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/j.kisu.2021.01.011","article-title":"International society of nephrology global kidney health atlas: Structures, organization and services for the management of kidney failure in North and East Asia","volume":"11","author":"Zhang","year":"2021","journal-title":"Kidney Int Suppl (2011)"},{"key":"R33-20260805","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1681\/ASN.2020040517","article-title":"Long-term exposure to ambient PM2.5 and increased risk of CKD prevalence in China","volume":"32","author":"Li","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"R34-20260805","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2023.115829","article-title":"Air pollution and the risk of incident chronic kidney disease in patients with diabetes: An exposure-response analysis","volume":"270","author":"Zhang","year":"2024","journal-title":"Ecotoxicol Environ Saf"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CM9.0000000000004162","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:01:47Z","timestamp":1785902507000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CM9.0000000000004162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":34,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000004162","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"2025-11-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}